Amount Raised
$7 Million
Round Type
Post-IPO Equity
BostonBiotechnologyDescription
Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer, announced today that it has entered into a subscription agreement to sell 1,213,000 shares of its common stock at a purchase price of $5.81 per share in a private placement to GKCC, LLC. GKCC, LLC is an entity controlled by a member of Elicio’s Board of Directors. Gross proceeds of the private placement are expected to be approximately $7.0 million, before deducting expenses
Quick answer
Elicio Therapeutics raised $7 Million in a Post-IPO Equity round, dated December 22, 2023. Elicio Therapeutics is based in Boston, Massachusetts, United States.
- How much did Elicio Therapeutics raise?
- Elicio Therapeutics raised $7 Million in a Post-IPO Equity round on December 22, 2023.
- What does Elicio Therapeutics do?
- Elicio Therapeutics is a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer.
- Where is Elicio Therapeutics based and how big is it?
- Elicio Therapeutics is based in Boston, Massachusetts, United States. Fundz records about 42 employees.
- Who are the decision-makers at Elicio Therapeutics?
- Fundz holds 1 contact at Elicio Therapeutics, including the Chief Scientific Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Elicio Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Inari raised $103M (Funding Round) on February 5, 2024.
- Impulse Dynamics raised $136M on February 5, 2024.
- Procyrion raised $58M (Series E) on February 5, 2024.
- Vektor Medical raised $16M (Series A) on February 5, 2024.
- Algorithmic Biologics raised $2.5M (Pre-Series A) on February 3, 2024.
- SPR Therapeutics raised $85M (Funding Round) on February 2, 2024.
Who to call at Elicio Therapeutics, and when
A new round usually means Elicio Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Elicio Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Elicio Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Elicio Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Elicio Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Elicio Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.